X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ACTAVIS (US) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ACTAVIS
EQUITY SHARE DATA
    PFIZER
Mar-18
ACTAVIS
Dec-14
PFIZER/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs2,36519,099-   
Low Rs1,62511,650-   
Sales per share (Unadj.) Rs430.33,439.2-  
Earnings per share (Unadj.) Rs78.7-429.2-  
Cash flow per share (Unadj.) Rs93.2315.5-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.57,459.4-  
Shares outstanding (eoy) m45.75265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.64.5 103.7%   
Avg P/E ratio x25.3-35.8 -70.8%  
P/CF ratio (eoy) x21.448.7 43.9%  
Price / Book Value ratio x3.42.1 165.0%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2714,087,999 2.2%   
No. of employees `0002.621.6 12.2%   
Total wages/salary Rs m3,1430-   
Avg. sales/employee Rs Th7,484.842,336.6 17.7%   
Avg. wages/employee Rs Th1,195.00-   
Avg. net profit/employee Rs Th1,369.1-5,283.2 -25.9%   
INCOME DATA
Net Sales Rs m19,685914,471 2.2%  
Other income Rs m1,143-2,282 -50.1%   
Total revenues Rs m20,828912,188 2.3%   
Gross profit Rs m5,003117,477 4.3%  
Depreciation Rs m663198,016 0.3%   
Interest Rs m428,844 0.0%   
Profit before tax Rs m5,479-111,666 -4.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,191 0.0%   
Tax Rs m1,878-5,741 -32.7%   
Profit after tax Rs m3,601-114,116 -3.2%  
Gross profit margin %25.412.8 197.8%  
Effective tax rate %34.35.1 666.8%   
Net profit margin %18.3-12.5 -146.6%  
BALANCE SHEET DATA
Current assets Rs m24,167481,809 5.0%   
Current liabilities Rs m9,544351,380 2.7%   
Net working cap to sales %74.314.3 520.8%  
Current ratio x2.51.4 184.7%  
Inventory Days Days5558 94.9%  
Debtors Days Days2966 43.3%  
Net fixed assets Rs m9,514111,666 8.5%   
Share capital Rs m4580-   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,8321,983,453 1.4%   
Long term debt Rs m251,039,368 0.0%   
Total assets Rs m36,9003,635,017 1.0%  
Interest coverage x1,305.5-2.9 -45,467.9%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.50.3 212.1%   
Return on assets %9.8-2.3 -416.5%  
Return on equity %13.4-5.8 -233.2%  
Return on capital %20.4-3.0 -678.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
CASH FLOW
From Operations Rs m3,318157,032 2.1%  
From Investments Rs m-2,383-375,996 0.6%  
From Financial Activity Rs m-1,104211,255 -0.5%  
Net Cashflow Rs m-169-7,708 2.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.01 Rs / USD

Compare PFIZER With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PFIZER With: AUROBINDO PHARMA  WOCKHARDT  SHASUN PHARMA  DR. DATSONS LABS  DIVIS LABORATORIES  



Today's Market

Indian Elections or Game of Thrones: What Excites You More?(Podcast)

As the TV war in Game of Thrones is set to conclude, we in India, are amidst our own battle for power - the 2019 Elections.

Related Views On News

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

The Best Trading Strategy in the World(Profit Hunter)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

Election Series: Why 'Liquor' is so Important to the Elections(The 5 Minute Wrapup)

Apr 19, 2019

When elections come around, liquor flows like water and everyone gets drunk with power...what does this mean for liquor stocks? Read one to find out from our very own election trading analyst, Vijay Bhambwani.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 26, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS